ReportWire

Tag: HECA

  • WHO experts to weigh whether world ready to end COVID emergency

    WHO experts to weigh whether world ready to end COVID emergency

    LONDON, May 4 (Reuters) – A panel of global health experts will meet on Thursday to decide if COVID-19 is still an emergency under the World Health Organization’s rules, a status that helps maintain international focus on the pandemic.

    The WHO first gave COVID its highest level of alert on Jan. 30, 2020, and the panel has continued to apply the label ever since, at meetings held every three months.

    However, a number of countries, such as the United States, have recently begun lifting their domestic states of emergency. WHO Director-General Dr Tedros Adhanom Ghebreyesus has said he hopes to end the international emergency this year.

    A final decision by Tedros based on the panel’s advice is expected in the coming days. There is no consensus yet on which way the panel may rule, advisors to the WHO and external experts told Reuters.

    “It is possible that the emergency may end, but it is critical to communicate that COVID remains a complex public health challenge,” said Professor Marion Koopmans, a Dutch virologist who is on the WHO panel. She declined to speculate further ahead of the discussions, which are confidential.

    One source close to negotiations said lifting the “public health emergency of international concern,” or PHEIC, label could impact global funding or collaboration efforts. Another said that the unpredictability of the virus made it hard to call at this stage. Others said it was time to move to living with COVID as an ongoing health threat, like HIV or tuberculosis.

    “All emergencies must come to an end,” said Lawrence Gostin, a law professor at Georgetown University in the United States who follows the WHO.

    “I expect WHO to end the public health emergency of international concern. If WHO does not end it… [this time], then certainly the next time the emergency committee meets.”

    Dr. Jarbas Barbosa, director of the Pan American Health Organization (PAHO), said he was concerned that a change in status would lead to complacency, with weaker surveillance and falling vaccination levels.

    “(The PHEIC) does not bring any kind any harm for countries but at the same time it keeps their attention,” he told journalists.

    Reporting by Jennifer Rigby in London and Emma Farge in Geneva; Editing by Alexandra Hudson

    Our Standards: The Thomson Reuters Trust Principles.

    Jennifer Rigby

    Thomson Reuters

    Jen reports on health issues affecting people around the world, from malaria to malnutrition. Part of the Health & Pharma team, recent notable pieces include an investigation into healthcare for young transgender people in the UK as well as stories on the rise in measles after COVID hit routine vaccination, as well as efforts to prevent the next pandemic. She previously worked at the Telegraph newspaper and Channel 4 News in the UK, as well as freelance in Myanmar and the Czech Republic.

    Source link

  • Russian charged with war crimes may brief U.N. Security Council

    Russian charged with war crimes may brief U.N. Security Council

    UNITED NATIONS, April 3 (Reuters) – Russia’s commissioner for children’s rights, who is wanted by the International Criminal Court on war crimes charges, is likely to brief an informal meeting of the U.N. Security Council this week, according to a note seen by Reuters on Monday.

    Russia, which holds the monthly rotating presidency of the 15-member body for April, told council members in a note that it plans to hold an informal meeting on Wednesday on Ukraine, focused on “evacuating children from conflict zone.”

    “Participants will hear ‘first hand’ information from the Presidential Commissioner for Children’s Rights of the Russian Federation, as well as from children evacuated from the conflict area,” read the note.

    The commissioner is Maria Lvova-Belova. The International Criminal Court (ICC) last month issued an arrest warrant against Russian President Vladimir Putin and Lvova-Belova, accusing them of illegally deporting hundreds of children from Ukraine, as well as the unlawful transfer of people to Russia from Ukraine since Moscow invaded on Feb. 24, 2022.

    “They cannot invite a credible briefer because they do not have any credibility on this issue,” Britain’s Deputy U.N. Ambassador James Kariuki told Reuters in a statement. “Russian leaders have been charged by the ICC with unlawfully deporting children from Ukraine to Russia. That is a war crime.”

    Russia’s U.N. Ambassador Vassily Nebenzia said on Monday that the meeting briefers would be announced shortly. Such meetings are held at U.N. headquarters, but not in the Security Council chamber, and briefings can be done virtually.

    ‘APRIL FOOL’S JOKE’

    Moscow has not concealed a program under which it has brought thousands of Ukrainian children to Russia but presents it as a humanitarian campaign to protect orphans and children abandoned in the conflict zone.

    Nebenzia told reporters last month that the informal meeting of Security Council members to be held on Wednesday had been planned long before the ICC announcement and it was not intended to be a rebuttal of the charges against Putin and Lvova-Belova.

    While a feature of Russia’s presidency, members do not need to be the rotating monthly president to hold such meetings.

    Russian Foreign Minister Sergei Lavrov is due to travel to New York to chair formal Security Council meetings later in the month on the Middle East and on “effective multilateralism through the defense of the principles of the U.N. Charter.”

    The 193-member U.N. General Assembly has criticized Russia for violating the founding U.N. Charter by invading its neighbor and called for a “comprehensive, just and lasting peace” in line with the principles of the U.N. Charter.

    Given Russia’s Security Council presidency started on April 1, U.S. Ambassador to the United Nations, Linda Thomas-Greenfield, told reporters on Monday: “It’s like an April Fool’s joke … We expect that they will behave professionally.”

    “But we also expect that they will use their seat to spread disinformation and to promote their own agenda as it relates to Ukraine, and we will stand ready to call them out at every single moment that they attempt to do that,” she said.

    Reporting by Michelle Nichols; Editing by Don Durfee and Bill Berkrot

    Our Standards: The Thomson Reuters Trust Principles.

    Source link

  • U.S. FDA proposes shift to annual COVID vaccine shots

    U.S. FDA proposes shift to annual COVID vaccine shots

    Jan 23 (Reuters) – The U.S. health regulator on Monday proposed one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it aims to simplify the country’s COVID-vaccine strategy.

    The U.S. Food and Drug Administration also asked its panel of external advisers to consider the usage of two COVID vaccine shots a year for some young children, older adults and persons with compromised immunity.The regulator proposed the need for routine selection of variants for updating the vaccine, similar to the way strains for flu vaccines are changed annually, in briefing documents ahead of a meeting of its panel on Thursday.

    The FDA hopes annual immunization schedules may contribute to less complicated vaccine deployment and fewer vaccine administration errors, leading to improved vaccine coverage rates.The agency’s proposal was on expected lines, following its announcement of its intention for the update last month.

    A nurse fills up syringes with the coronavirus disease (COVID-19) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin

    The Biden administration has also been planning for a campaign of vaccine boosters every fall season.

    Currently, most people in the United States need to first get two doses of the original COVID vaccine spaced at least three to four weeks apart, depending on the vaccine, followed by a booster dose a few months later.

    Pfizer’s primary vaccine doses for children and people involve three shots, with the third a bivalent shot given about two months later.

    If the panel votes in favor of the proposal, Pfizer Inc (PFE.N) and Moderna Inc’s (MRNA.O) bivalent vaccines, which target both the Omicron and the original variants, would be used for all COVID vaccine doses, and not just as boosters.

    Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber and Shinjini Ganguli

    Our Standards: The Thomson Reuters Trust Principles.

    Source link

  • Analysis: Russian mercenary boss courts Putin with Ukrainian battlefield success

    Analysis: Russian mercenary boss courts Putin with Ukrainian battlefield success

    • Wagner Group spearheaded assault on Ukraine’s Soledar
    • Mercenary chief, in PR push, claims credit for Wagner
    • Success hailed by some, played down by others

    LONDON, Jan 13 (Reuters) – In the twilight of the Soviet Union, Yevgeny Prigozhin was languishing in prison for theft. Now as the founder of Russia’s most powerful mercenary group, he is vying for Vladimir Putin’s favour by claiming a rare battlefield win in Ukraine.

    His aim is to leverage the success that Wagner Group, his mercenary outfit, had this week in pushing Ukrainian forces out of the salt mining town of Soledar, a move that revives Russian plans to seize more of eastern Ukraine after multiple defeats.

    Russia claimed victory on Friday but Ukraine said its troops were still fighting in the town. Reuters could not immediately verify the situation.

    Prigozhin, 61, who is sanctioned in the West and casts himself as a ruthless patriot, had posed in combat gear with his men in a salt mine beneath Soledar and said they were fighting alone, an assertion initially contradicted by defence officials.

    The Kremlin on Thursday spoke of the “absolutely heroic selfless actions” of those fighting in Soledar. The defence ministry on Friday attributed victory to its airborne units, missile forces and “artillery of a grouping of Russian forces”.

    Prigozhin said Russian officials were not giving his forces due credit.

    “They constantly try to steal victory from the Wagner PMC (private military company) and talk about the presence of other unknown people just to belittle Wagner’s merits,” he complained.

    The defence ministry responded hours later with a new statement “to clarify” the situation which acknowledged that Wagner fighters, whose actions it hailed as “courageous and selfless,” had been the ones to storm the town.

    Some commentators have said Prigozhin could one day be made defence minister, but it is not fully clear how much influence the businessman from St Petersburg has gained with Putin, who tends to balance factions with a strategy of divide and rule.

    ‘A NEW HERO’

    Prominent Putin supporters, some with access to the Russian leader, have contrasted Prigozhin’s progress with what they say has been a less impressive performance by the regular military.

    Sergei Markov, a former Kremlin adviser, has hailed the shaven-headed mercenary chief as “a new hero.”

    “Prigozhin has flaws too. But I won’t tell you about them. Because Prigozhin and Wagner are now Russia’s national treasure. They are becoming a symbol of victory,” Markov wrote on his blog, saying they should be given more resources by the state.

    Margarita Simonyan, editor-in-chief of the state-controlled RT channel and close to the Kremlin, thanked Prigozhin for Soledar.

    Abbas Gallyamov, a former Kremlin speech writer, suggested on his blog that Prigozhin was manoeuvring in case Putin removed Defence Minister Sergei Shoigu, 67, his long-standing ally.

    Prigozhin has played down the idea he is seeking official elevation in the past, while not emphatically ruling it out. His press service, and the Kremlin, did not immediately reply to requests for fresh comment.

    Putin has said Wagner does not represent the state and is not breaking Russian law and has the right to work and promote its business interests anywhere in the world.

    One of the military bloggers who help shape Russians’ view of the conflict likened Prigozhin to a Roman centurion licensed to operate above and outside the law to achieve Putin’s goals.

    “A couple more successful Wagner operations and online votes proposing Prigozhin for Minister of Defence will cease to be fantasy,” said Zhivov Z.

    Yet Igor Girkin, a Russian nationalist and former Federal Security Service officer who helped launch the original Donbas war in 2014 and is under U.S. sanctions, has said Prigozhin is careless with the lives of his men. He has also said capturing Soledar and nearby Bakhmut would not be militarily significant.

    Prigozhin, nicknamed “Putin’s Chef” by Western media because he once ran a floating restaurant in St Petersburg where Putin ate, has plenty to gain or lose.

    He has his own future to consider at a time of tumult as well as the commercial interests of Wagner, which Russian officials say has military and mining contracts in Africa and is active in Syria. He also has a vast catering company serving state entities, as well as troll farms and media outlets.

    “In essence, he is a private businessman who is highly dependent on how his relations with the authorities are structured. This is a very vulnerable position,” said Tatiana Stanovaya, founder of the R.Politik analysis firm.

    The attendance on a Wagner training course this month of the governor of Russia’s Kursk region bordering Ukraine looked like another way for Prigozhin to enhance his connections, she said.

    ‘UNSPECIFIED SAFEGUARDS’

    Russia has allowed Prigozhin to recruit tens of thousands of convicts from its prisons for Wagner, which U.S. officials say is a 50,000-strong force, and let him equip them with tanks, aircraft and missile defence systems.

    It has also stood by while he flung sometimes profane criticism at the top brass, although some Western military analysts suggested the appointment of the most senior general to lead the war in Ukraine was designed to balance his influence.

    Before Russia’s invasion, something Moscow calls “a special military operation”, Prigozhin had denied his Wagner connection. In September, he said he had founded the mercenary group in 2014.

    Despite its sometimes publicly strained ties with the Russian defence ministry, some Western military analysts suspect Wagner is closely affiliated with it.

    Leonid Nevzlin, an Israel-based former executive at oil major Yukos which he says was illegally appropriated by the Russian state, something it denies, said this week there was a risk Wagner could throw off Kremlin control.

    One source close to the Russian authorities, who declined to be named because they were not authorised to speak to the media, said the Kremlin viewed Prigozhin as a useful operator but maintained unspecified safeguards over leaders of armed groups.

    “There is a ceiling (of growth) and mechanisms in place,” said the source, who declined to provide more details.

    Reporting by Andrew Osborn; editing by Philippa Fletcher

    Our Standards: The Thomson Reuters Trust Principles.

    Source link

  • Omicron subvariant XBB.1.5 accounts for 43% of U.S. COVID cases – CDC

    Omicron subvariant XBB.1.5 accounts for 43% of U.S. COVID cases – CDC

    Jan 13 (Reuters) – The fast-spreading Omicron subvariant XBB.1.5 is estimated to account for 43% of the COVID-19 cases in the United States for the week ended Jan. 14, data from the Centers for Disease Control and Prevention showed on Friday.

    The subvariant accounted for about 30% of cases in the first week of January, higher than the 27.6% the CDC estimated last week.

    XBB.1.5, which is related to Omicron, is currently the most transmissible variant. It is an offshoot of XBB, first detected in October, which is itself made from a combination of two other Omicron subvariants.

    The World Health Organization (WHO) said earlier this week XBB.1.5 may spur more COVID-19 cases based on genetic characteristics and early growth rate estimates.

    While it is unclear if XBB.1.5 can cause its own wave of global infections, experts say the current booster shots continue to protect against severe symptoms, hospitalization and death.

    WHO Director General Tedros Adhanom Ghebreyesus tweeted last week the subvariant has been on the rise globally and has been identified in over 25 countries.

    The rise in the new variant correlated with an uptick in COVID-19 cases in United States over the last six weeks.

    Increased prevalence of XBB.1.5 cases has eclipsed the previously dominant Omicron subvariant BQ.1.1 and BQ.1, which were offshoots of BA.5. The two strains together accounted for 44.7% of cases in the United States in the week ended Jan. 14, compared with 53.2% a week ago, the CDC said.

    Reporting by Khushi Mandowara and Sriparna Roy in Bengaluru; Editing by Maju Samuel and Shounak Dasgupta

    Our Standards: The Thomson Reuters Trust Principles.

    Source link

  • U.S. FDA allows abortion pills to be sold at retail pharmacies

    U.S. FDA allows abortion pills to be sold at retail pharmacies

    WASHINGTON, Jan 3 (Reuters) – The U.S. Food and Drug Administration (FDA) will allow retail pharmacies to offer abortion pills in the United States for the first time, the agency said on Tuesday, even as more states seek to ban medication abortion.

    The regulatory change will potentially expand abortion access as President Joe Biden’s administration wrestles with how best to protect abortion rights after they were sharply curtailed by the Supreme Court’s decision to overturn the landmark Roe v Wade ruling and the state bans that followed.

    Pharmacies can start applying for certification to distribute abortion pill mifepristone with one of the two companies that make it, and if successful they will be able to dispense it directly to patients upon receiving a prescription from a certified prescriber.

    The FDA had first said it would be making those changes in December 2021 when it announced it would relax some risk evaluation and mitigation strategies, or REMS, on the pill, that had been in place since the agency approved it in 2000 and were lifted temporarily in 2021 due to the COVID-19 pandemic.

    The changes included permanently removing restrictions on mail order shipping of the pills and their prescription through telehealth.

    The agency finalized the changes on Tuesday after reviewing supplemental applications from Danco Laboratories and GenBioPro, the two companies that make the drug in the United States.

    “Under the Mifepristone REMS Program, as modified, Mifeprex and its approved generic can be dispensed by certified pharmacies or by or under the supervision of a certified prescriber,” the agency said on its website on Tuesday.

    Mifeprex is the brand name version of mifepristone which, in combination with a second drug called misoprostol that has various uses including miscarriage management, induces an abortion up to 10 weeks into a pregnancy in a process known as medication abortion.

    Abortion rights activists say the pill has a long track record of being safe and effective, with no risk of overdose or addiction. In several countries, including India and Mexico, women can buy them without a prescription to induce abortion.

    “Today’s news is a step in the right direction for health equity,” Planned Parenthood President Alexis McGill Johnson said in a statement.

    “Being able to access your prescribed medication abortion through the mail or to pick it up in person from a pharmacy like any other prescription is a game changer for people trying to access basic health care,” Johnson added.

    NO EQUAL ACCESS

    The regulatory change will, however, not provide equal access to all people, GenBioPro, which makes the generic version of mifepristone, said in a statement.

    Abortion bans, some targeting mifepristone, have gone into effect in more than a dozen states since the U.S. Supreme Court overturned the constitutional right to terminating pregnancies when it scrapped the 1973 Roe v. Wade ruling last year.

    Women in those states could potentially travel to other states to obtain medication abortion.

    The president of anti-abortion group SBA Pro-Life America, Marjorie Dannenfelser, said the latest FDA move endangers women’s safety and the lives of unborn children.

    “State lawmakers and Congress must stand as a bulwark against the Biden administration’s pro-abortion extremism,” she said in a statement.

    FDA records show a small mortality case number associated with mifepristone. As of June 2021, there were reports of 26 deaths linked with the pill out of 4.9 million people estimated to have taken it since it was approved in September 2000.

    Retail pharmacies will have to weigh whether or not to offer the pill given the political controversy surrounding abortion, and determine where they can do so.

    A spokesperson for CVS Health (CVS.N) said the drugstore chain owner was reviewing the updated REMS “drug safety program certification requirements for mifepristone to determine the requirements to dispense in states that do not restrict the dispensing of medications prescribed for elective termination of pregnancy.”

    A spokesperson for Walgreens (WBA.O), one of the largest U.S. pharmacies, said the company was also reviewing the FDA’s regulatory change. “We will continue to enable our pharmacists to dispense medications consistent with federal and state law.”

    Reporting by Ahmed Aboulenein; Additional reporting by Eric Beech in Washington, Shivani Tanna, Rahat Sandhu, and Kanjyik Ghosh in Bengaluru; Editing by Himani Sarkar

    Our Standards: The Thomson Reuters Trust Principles.

    Ahmed Aboulenein

    Thomson Reuters

    Washington-based correspondent covering U.S. healthcare and pharmaceutical policy with a focus on the Department of Health and Human Services and the agencies it oversees such as the Food and Drug Administration, previously based in Iraq and Egypt.

    Source link

  • Medical staff in China’s hospitals say COVID-19 ripping through their ranks

    Medical staff in China’s hospitals say COVID-19 ripping through their ranks

    HONG KONG, Dec 14 (Reuters) – A growing number of China’s doctors and nurses are catching COVID-19 and some have been asked to keep working, as people showing mostly moderate symptoms throng hospitals and clinics, according to medical staff and dozens of posts on social media.

    China’s health authority did not immediately respond to a request for comment on infections among medical staff.

    Health experts say China’s sudden loosening of strict COVID rules is likely to trigger a surge in severe cases in coming months, and hospitals in big cities are already showing signs of strain.

    Reuters was unable to immediately get verification from hospitals on waiting times and bed utilisation rates, but photographs circulated on social media showed patients in Beijing and neighbouring Baoding waiting for hours to get treated.

    Health officials have been recommending that people with mild COVID symptoms quarantine at home and have also said most of the cases reported in the country are mild or asymptomatic.

    “Our hospital is overwhelmed with patients. There are 700, 800 people with fever coming every day,” said a doctor surnamed Li at a tertiary hospital in Sichuan province.

    “We are running out of medicine stocks for fever and cold, now waiting for delivery from our suppliers. A few nurses at the fever clinic were tested positive, there aren’t any special protective measures for hospital staff and I believe many of us will soon get infected,” Li added.

    A nurse at another hospital in Chengdu said: “I was swamped with nearly 200 patients with COVID symptoms last night.”

    Ben Cowling, an epidemiologist at Hong Kong University, said insufficient medical resources to cope with an overload of COVID cases contributed to a surge in deaths in Hong Kong when infections peaked there earlier this year, and he warned that the same was going to happen in China.

    “One of the reasons we had such a high mortality rate (in Hong Kong) is because we simply didn’t have enough hospital resources to cope in the surge. And unfortunately, that is what is going to happen in about one to two months time in the mainland,” Cowling said.

    He said a surge in severe cases coupled with a surge of mild cases among the elderly who needed monitoring overwhelmed Hong Kong’s hospitals, and recommended separate isolation facilities for the elderly with mild cases to free up hospital beds.

    State media Xinhua reported on Tuesday in capital Beijing 50 patients are currently in a serious or critical condition in hospital with COVID.

    ‘WHAT A MESS’

    The sudden loosening of restrictions has sparked long queues outside fever clinics since last week in a worrying sign that a wave of infections is building, even though official tallies of new cases have trended lower recently as authorities eased back on testing.

    Some hospitals in Beijing have up to 80% of their staff infected, but many of them are still required to work due to staff shortages, a doctor in a large public hospital in Beijing told Reuters, adding he has spoken to his peers at other big hospitals in the capital.

    All operations and surgeries have been cancelled at his hospital unless the patient is “dying tomorrow”, he said, declining to be named due to the sensitivity of the subject.

    A post on the Weibo social media platform recounted a recent experience at the emergency ward at Beijing Hospital.

    “Those who have not been to the emergency department of Beijing Hospital don’t know what a mess it has become,” wrote a Weibo user called Moshang. The post went on to say that people in serious need of surgery were being made to wait.

    Beijing Hospital did not immediately respond to a Reuters’ request for comment.

    Wan Ling, a head nurse at a hospital in Huashan in China’s Anhui province, wrote on Weibo that many of her infected colleagues were relatively serious and had high fever.

    Several doctors from Wuhan province’s top public hospital Tongji have also tested positive for COVID-19, but since Sunday have not been allowed to take leave, a pharmaceutical sales representative with direct knowledge of the matter told Reuters, declining to be named, as the information is not public.

    “They have to stay at work while they are sick,” said the person who regularly visits the hospital and spoke to its doctors recently.

    Tongji hospital did not immediately respond to a Reuters request for comment.

    Reporting by the Beijing newsroom, David Stanway and the Shanghai newsroom, Julie Zhu and Selena Li in Hong Kong; Writing by Farah Master; Editing by Miyoung Kim & Simon Cameron-Moore

    Our Standards: The Thomson Reuters Trust Principles.

    Source link

  • U.S. Supreme Court takes up Texas abortion case, lets ban remain

    U.S. Supreme Court takes up Texas abortion case, lets ban remain

    Oct 22 (Reuters) – The U.S. Supreme Court on Friday agreed to hear on Nov. 1 a challenge to a Texas law that imposes a near-total ban on the procedure and lets private citizens enforce it – a case that could dramatically curtail abortion access in the United States if the justices endorse the measure’s unique design.

    The justices took up requests by President Joe Biden’s administration and abortion providers to immediately review their challenges to the law. The court, which on Sept. 1 allowed the law to go into effect, declined to act on the Justice Department’s request to immediately block enforcement of the measure.

    The court will consider whether the law’s unusual private-enforcement structure prevents federal courts from intervening to strike it down and whether the federal government is even allowed to sue the state to try to block it.

    Register now for FREE unlimited access to Reuters.com

    The measure bans abortion after about six weeks of pregnancy, a point when many women do not yet realize they are pregnant. It makes an exception for a documented medical emergency but not for cases of rape or incest.

    Liberal Justice Sotomayor dissented from the court’s deferral of a decision on whether to block enforcement of the law while the litigation continues. Sotomayor said the law’s novel design has suspended nearly all abortions in Texas, the second most populous U.S. state, with about 29 million people.

    “The state’s gambit has worked. The impact is catastrophic,” Sotomayor wrote.

    The Texas dispute is the second major abortion case that the court, which has a 6-3 conservative majority, has scheduled for the coming months, with arguments set for Dec. 1 over the legality of a restrictive Mississippi abortion law.

    The Texas and Mississippi measures are among a series of Republican-backed laws passed at the state level limiting abortion rights – coming at a time when abortion opponents are hoping that the Supreme Court will overturn the landmark 1973 Roe v. Wade that legalized the procedure nationwide.

    Mississippi has asked the justices to overturn Roe v. Wade, and the Texas attorney general on Thursday signaled that he also would like to see that ruling fall.

    Lower courts already have blocked Mississippi’s law banning abortions starting at 15 weeks of pregnancy.

    The Texas measure takes enforcement out of the hands of state officials, instead enabling private citizens to sue anyone who performs or assists a woman in getting an abortion after cardiac activity is detected in the embryo. That feature has helped shield the law from being immediately blocked as it made it more difficult to directly sue the state.

    Individual citizens can be awarded a minimum of $10,000 for bringing successful lawsuits under the law. Critics have said this provision lets people act as anti-abortion bounty hunters, a characterization its proponents reject.

    Nancy Northup, president of the Center for Reproductive Rights, which is representing the abortion providers, said Friday’s decision to hear their case “brings us one step closer to the restoration of Texans’ constitutional rights and an end to the havoc and heartache of this ban.”

    Alexis McGill Johnson, president of healthcare and abortion provider Planned Parenthood, said it is “devastating” that the justices did not immediately block a law that already has had a “catastrophic impact” after being in effect nearly two months.

    “Patients who have the means have fled the state, traveling hundreds of miles to access basic care, and those without means have been forced to carry pregnancies against their will,” she added.

    Kimberlyn Schwartz, a spokesperson for the Texas Right to Life anti-abortion group, praised the court’s action, saying it “will continue to save an estimated 100 babies per day, and because the justices will actually discuss whether these lawsuits are valid in the first place.”

    The Supreme Court only rarely decides to hear cases before lower courts have ruled, indicating that the justices have deemed the Texas matter of high public importance and requiring immediate review.

    The Justice Department filed its lawsuit in September challenging the Texas law, arguing that it is unconstitutional and explicitly designed to evade judicial review.

    Rulings in Texas and Mississippi cases are due by the end of next June, but could come sooner.

    Register now for FREE unlimited access to Reuters.com

    Reporting by Andrew Chung in New York; Editing by Will Dunham

    Our Standards: The Thomson Reuters Trust Principles.

    Source link